Retrospektive Untersuchung zum Einsatz von Dexpanthenol-Nasenspray (NasicurR) bei der Behandlung von Patienten mit Schlafapnoesyndrom und nCPAP/bilevel-Therapie. Retrospective Investigation on the Use of Dexpanthenol Nasal Spray (NasicurR) in the Treatment of Patients with Sleep Apnoea Syndrome and nCPAP/Bilevel Therapy

Brander PE, 1999, Respiration, 66, 128

[2]M Gugger, C Bassetti, and S Boxdor : Effectiveness of nasal CPAP-treatment (continous positive airway pressure). Ther Umsch . 57 (7 ): 444 -448 , 2000 .

[3]C Crowe-McCann, G Nino-Murcia, and C Guilleminault, Nasal CPAP: The Stanford experience. In: Guilleminault C, Partinen M: Obstructive sleep apnea syndrome: clinical research and treatment . Raven Press, New York,1990 .

Hoffstein V, 1992, Am Rev Respir, 145, 841, 10.1164/ajrccm/145.4_Pt_1.841

Kehrl W, 1998, Laryngorhinootologie, 77, 506, 10.1055/s-2007-997014

[6]Kommentar zum DAB 10 - 3.Nachtrag 1994 ; Deutsches Arzneibuch D12, 6. Lfg. 1996.

Kuhl S, 1997, Laryngorhinootologie, 76, 608, 10.1055/s-2007-997488

Maritns De Araujo MT, 2000, Chest, 117, 142

Massie CA, 2000, Chest, 117, 925

Meurice JC, 1994, Chest, 105, 429

Nino-Murcia G, 1989, West J Med, 150, 165

Pepin JL, 1995, Chest, 107, 375

Randerath WJ, 2002, Eur Respir J, 20, 183

Verse T, 2000, HNO, 48, 706

Verse T, 1999, Laryngorhinootologie, 78, 491, 10.1055/s-2007-996914

Waldhorn RE, 1990, Chest, 97, 33

Wiest GH, 2000, Respir Med, 94, 364